Evidence map›Paper›PMID 30700932›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2018

Identification of liver metastasis-associated genes in human colon carcinoma by mRNA profiling.

Jianling Liu, Dan Wang, Chaoqi Zhang, Zhen Zhang, Xinfeng Chen, Jingyao Lian, Jinbo Liu, Guixian Wang, Weitang Yuan, Zhenqiang Sun and 7 more

Abstract read
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Frontiers in molecular biosciences · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Jianling LiuBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Dan WangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Chaoqi ZhangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhen ZhangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Xinfeng ChenBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Jingyao LianBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Jinbo LiuDepartment of Anorectal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Guixian WangDepartment of Anorectal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Weitang YuanDepartment of Anorectal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhenqiang SunDepartment of Anorectal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Weijia WangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Mengjia SongBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yaping WangHenan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou 450052, China.
Qian WuBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Ling CaoBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Dong WangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yi ZhangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLiver metastasis, which contributes substantially to high mortality, is the most common recurrent mode of colon carcinoma. Thus, it is necessary to identify genes implicated in metastatic colonization of the liver in colon carcinoma.

methodsWe compared mRNA profiling in 18 normal colon mucosa (N), 20 primary tumors (T) and 19 liver metastases (M) samples from the dataset GSE49355 and GSE62321 of Gene Expression Omnibus (GEO) database. Gene ontology (GO) and pathways of the identified genes were analyzed. Co-expression network and protein-protein interaction (PPI) network were employed to identify the interaction relationship. Survival analyses based on The Cancer Genome Atlas (TCGA) database were used to further screening. Then, the candidate genes were validated by our data.

resultsWe identified 22 specific genes related to liver metastasis and they were strongly associated with cell migration, adhesion, proliferation and immune response. Simultaneously, the results showed that C-X-C motif chemokine ligand 14 (CXCL14) might be a favorable prediction factor for survival of patients with colon carcinoma. Importantly, our validated data further suggested that lower CXCL14 represented poorer outcome and contributed to metastasis. Gene set enrichment analysis (GSEA) showed that CXCL14 was negatively related to the regulation of stem cell proliferation and epithelial to mesenchymal transition (EMT).

conclusionsCXCL14 was identified as a crucial anti-metastasis regulator of colon carcinoma for the first time, and might provide novel therapeutic strategies for colon carcinoma patients to improve prognosis and prevent metastasis.

Indexed as

Colon carcinomafunctions annotationliver metastasismRNA profiling

Identifiers

PMID30700932
PMCPMC6328509
OpenAlexW2911206172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.